Retinal Degeneration Fund
Retinal Degeneration Fund makes mission-related investments in therapeutic companies with projects nearing clinical testing.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Retinal Degeneration Fund Information
Geographic Data
Address: 223 S. West Street,
City: Raleigh
State: NC
Zip: 27603
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Retinal Degeneration Fund helps in accelerating life-changing outcomes for people with retinal degenerations through direct mission-related investments in therapeutic companies. The Retinal Degeneration Fund (RD Fund) is a not-for-profit subsidiary of the Foundation Fighting Blindness launched in 2018.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2021 | Opus Genetics | Seed Round | 0 |
| 9/2022 | SparingVision | Series B | 0 |
| 6/2022 | Nacuity Pharmaceuticals | Series B | 0 |
| 5/2021 | Vedere Bio ll | Series A | 0 |
| 1/2023 | Perceive Biotherapeutics | Series B | 0 |
| 12/2020 | Atsena Therapeutics | Series A | 0 |
| 11/2020 | Stargazer Pharmaceuticals | Series A | 0 |
| 1/2022 | SalioGen Therapeutics | Series B | 0 |
| 6/2022 | Nacuity Pharmaceuticals | Series B | 0 |
| 1/2022 | SalioGen Therapeutics | Series B | 0 |
| 9/2021 | Opus Genetics | Seed Round | 0 |
| 5/2021 | Vedere Bio ll | Series A | 0 |
| 12/2020 | Atsena Therapeutics | Series A | 0 |
| 11/2020 | Stargazer Pharmaceuticals | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
